文献速递神经MR

深度迁移学习与影像组学特征预测高级别胶质瘤患者生存

Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-12-19

本研究纳入本院50例和癌症基因组图谱128例高级别胶质瘤患者,计算348个手工影像组学特征和8192个深度特征,经特征选择和弹性网Cox建模区分长期与短期生存者。本院队列log-rank检验P值<.001,癌症基因组图谱队列P值为.014,混合队列P值为.035。

要点

  • 联合深度与影像组学特征模型可将高级别胶质瘤患者分为长期和短期生存组。
  • 本院50例队列log-rank检验P值<.001,癌症基因组图谱128例队列P值为.014。
  • 本院50例与癌症基因组图谱58例混合队列log-rank检验P值为.035。

核心结论

  • 结合深度特征和影像组学特征的深度学习模型可将高级别胶质瘤患者二分为长期和短期生存者。

研究设计与样本

  • 研究纳入本院50例高级别胶质瘤患者和癌症基因组图谱128例高级别胶质瘤患者。
  • 对每例患者计算348个手工影像组学特征和预训练卷积神经网络生成的8192个深度特征。
  • 应用特征选择和弹性网Cox建模区分长期与短期生存者。

诊断标准与关键数值

  • 本院50例队列中联合特征分析框架区分长期与短期生存组的log-rank检验P值<.001。
  • 癌症基因组图谱128例队列中该框架区分长期与短期生存者的log-rank检验P值为.014。
  • 本院50例与癌症基因组图谱58例混合队列的log-rank检验P值为.035。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Patient survival in high-grade glioma remains poor, despite the recent developments in cancer treatment. As new chemo-, targeted molecular, and immune therapies emerge and show promising results in clinical trials, image-based methods for early prediction of treatment response are needed. Deep learning models that incorporate radiomics features promise to extract information from brain MR imaging that correlates with response and prognosis. We report initial production of a combined deep learning and radiomics model to predict overall survival in a clinically heterogeneous cohort of patients with high-grade gliomas.

MATERIALS AND METHODS: Fifty patients with high-grade gliomas from our hospital and 128 patients with high-grade glioma from The Cancer Genome Atlas were included. For each patient, we calculated 348 hand-crafted radiomics features and 8192 deep features generated by a pretrained convolutional neural network. We then applied feature selection and Elastic Net-Cox modeling to differentiate patients into long- and short-term survivors.

RESULTS: In the 50 patients with high-grade gliomas from our institution, the combined feature analysis framework classified the patients into long- and short-term survivor groups with a log-rank test P value < .001. In the 128 patients from The Cancer Genome Atlas, the framework classified patients into long- and short-term survivors with a log-rank test P value of .014. For the mixed cohort of 50 patients from our institution and 58 patients from The Cancer Genome Atlas, it yielded a log-rank test P value of .035.

CONCLUSIONS: A deep learning model combining deep and radiomics features can dichotomize patients with high-grade gliomas into long- and short-term survivors.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Han W, Qin L, Bay C, et al. Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas. AJNR Am J Neuroradiol. 2019. PMID: 31857325. doi:10.3174/ajnr.A6365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。